BioMarin Pharmaceutical Inc. - Company Profile and SWOT Analysis

January 2024 | 47 pages | ID: B84E96DC7ABEN
MarketLine

Abstracts

BioMarin Pharmaceutical Inc. %li%Company Profile and SWOT Analysis

Summary

BioMarin Pharmaceutical Inc. %li%Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

BioMarin Pharmaceutical Inc. (BioMarin or 'the company') is a biotechnology company, that is engaged in development and commercialization of biopharmaceuticals for the treatment of rare diseases and medical conditions. The company manufactures pharmaceuticals for treatment of serious diseases and medical conditions such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), achondroplasia, phenylketonuria (PKU), late infantile neuronal ceroid lipofuscinosis (CLN2), and hemophilia A. BioMarin markets its products under the brands, BioMarin, Brineura, Kuvan, Naglazyme, Palynziq, Roctavian, Vimizim, Voxzogo, and Aldurazyme. It operates in the US, Europe, Latin America, and other regions of the world. The company is headquartered in San Rafael, California, the US.

Scope

• Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
• An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
• Intelligence on BioMarin Pharmaceutical Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on BioMarin Pharmaceutical Inc.'s business structure, strategy and prospects.

Contents

Table of Contents
Company Snapshot
BioMarin Pharmaceutical Inc.: Company Overview
BioMarin Pharmaceutical Inc.: Overview and Key Facts
BioMarin Pharmaceutical Inc.: Overview
BioMarin Pharmaceutical Inc.: Key Facts
BioMarin Pharmaceutical Inc.: Key Employees
BioMarin Pharmaceutical Inc.: Key Employee Biographies
BioMarin Pharmaceutical Inc.: Major Products and Services
BioMarin Pharmaceutical Inc.: Management Statement
BioMarin Pharmaceutical Inc.: Locations and Subsidiaries
BioMarin Pharmaceutical Inc.: Key Competitors
BioMarin Pharmaceutical Inc.: Company Analysis
BioMarin Pharmaceutical Inc.: Business Description
BioMarin Pharmaceutical Inc.: SWOT Analysis
BioMarin Pharmaceutical Inc.: SWOT Overview
BioMarin Pharmaceutical Inc.: Strengths
BioMarin Pharmaceutical Inc.: Weaknesses
BioMarin Pharmaceutical Inc.: Opportunities
BioMarin Pharmaceutical Inc.: Threats
BioMarin Pharmaceutical Inc.: Corporate Financial Deals Activity
BioMarin Pharmaceutical Inc.: Financial Deals Overview
BioMarin Pharmaceutical Inc.: Targets and Partners
BioMarin Pharmaceutical Inc.: Top Deals 2020 - 2024YTD*
BioMarin Pharmaceutical Inc.: Capital Raising
BioMarin Pharmaceutical Inc.: Partnership
BioMarin Pharmaceutical Inc.: Divestments
BioMarin Pharmaceutical Inc.: Private Equity and Ownership
BioMarin Pharmaceutical Inc.: Recent Developments
BioMarin Pharmaceutical Inc.: News and Events Summary
BioMarin Pharmaceutical Inc.: Business Expansion
BioMarin Pharmaceutical Inc.: Corporate Governance
BioMarin Pharmaceutical Inc.: Financial Deals
BioMarin Pharmaceutical Inc.: Financial Performance
BioMarin Pharmaceutical Inc.: Market Developments
BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
BioMarin Pharmaceutical Inc.: Research & Development
BioMarin Pharmaceutical Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: BioMarin Pharmaceutical Inc.: Key Facts
Table 2: BioMarin Pharmaceutical Inc.: Key Employees
Table 3: BioMarin Pharmaceutical Inc.: Locations and Subsidiaries
Table 4: BioMarin Pharmaceutical Inc.: Key Competitors
Table 5: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Table 7: BioMarin Pharmaceutical Inc.: Targets and Partners
Table 8: BioMarin Pharmaceutical Inc.: Top Deals 2020 - 2024YTD*
Table 9: BioMarin Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
Table 10: BioMarin Pharmaceutical Inc.: Capital Raising by Deal Type (2020 - YTD*2024)
Table 11: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
Table 12: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
Table 13: BioMarin Pharmaceutical Inc.: Divestments Volume and Value Trend (2020 - YTD*2024)
Table 14: BioMarin Pharmaceutical Inc.: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
Table 15: BioMarin Pharmaceutical Inc.: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)
Table 16: BioMarin Pharmaceutical Inc.: News and Events Summary
Table 17: BioMarin Pharmaceutical Inc.: Business Expansion
Table 18: BioMarin Pharmaceutical Inc.: Corporate Governance
Table 19: BioMarin Pharmaceutical Inc.: Financial Deals
Table 20: BioMarin Pharmaceutical Inc.: Financial Performance
Table 21: BioMarin Pharmaceutical Inc.: Market Developments
Table 22: BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
Table 23: BioMarin Pharmaceutical Inc.: Research & Development
Table 24: BioMarin Pharmaceutical Inc.: Strategy and Operations

List Of Figures

LIST OF FIGURES

Figure 1: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Figure 3: BioMarin Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
Figure 4: BioMarin Pharmaceutical Inc.: Capital Raising by Deal Type (2020 - YTD*2024)
Figure 5: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
Figure 6: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
Figure 7: BioMarin Pharmaceutical Inc.: Divestments Volume and Value Trend (2020 - YTD*2024)
Figure 8: BioMarin Pharmaceutical Inc.: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
Figure 9: BioMarin Pharmaceutical Inc.: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)